Syngen Biotech Co

Syngen Biotech Co Net Margin

The Net Profit Margin of Syngen Biotech Co (8279.TWO) as of Nov 4, 2026 is 12.71 %. In the previous year, Net Profit Margin was 11.93 % — a change of 6.56% (higher).

Net Margin

12.71 %

YoY

6.56%

Last updated:

Net Profit Margin of Syngen Biotech Co is 2025 12.71 % . Net Profit Margin of Syngen Biotech Co was 2024 11.93 % . It decreases by 6.56% higher compared to the previous year.

Syngen Biotech Co's net margin stands at 12.7%, down from 16.2% several years earlier.

The Syngen Biotech Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
12.40 TWD
Jan 1, 2019
14.55 TWD
Jan 1, 2020
16.44 TWD
Jan 1, 2021
16.16 TWD
Jan 1, 2022
16.64 TWD
Jan 1, 2023
14.96 TWD
Jan 1, 2024
11.93 TWD
Jan 1, 2025
12.71 TWD
The Syngen Biotech Co Net Margin history
YEARNet MarginYoY
12.71 %+6.56%
11.93 %-20.25%
14.96 %-10.10%
16.64 %+2.96%
16.16 %-1.67%
16.44 %+12.96%
14.55 %+17.33%
12.40 %-20.26%
15.55 %+32.64%
11.72 %+12.85%
10.39 %+66.08%
6.26 %+11,639.95%
0.05 %-34.02%
0.08 %-39.73%
0.13 %-144.72%
-0.30 %-44.47%
-0.54 %-41.36%
-0.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Syngen Biotech Co Stock analysis

What does Syngen Biotech Co do? Syngen Biotech Co., Ltd. generates revenue through the manufacture and sale of microbial pharmaceuticals and biochemical nutrition products. The company's portfolio includes active pharmaceutical ingredients, health food raw materials, and animal health products. Additionally, the firm offers medical equipment such as bone density analyzers, blood glucose analyzers, and biochemical analyzers to its customer base. Syngen Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syngen Biotech Co stock

Net Profit Margin of Syngen Biotech Co is 12.71 % in 2025.

Net Profit Margin of Syngen Biotech Co changed from 11.93 % to 12.71 %, representing a 6.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Syngen Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Syngen Biotech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Syngen Biotech Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Syngen Biotech Co